SNO Brain Metastases 2020

Presentations

Tucatinib | Breast Cancer | Abstract 1005

Tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB)